These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis. Shammas NW; Jones-Miller S; Lemke J J Vasc Interv Radiol; 2016 Aug; 27(8):1195-203. PubMed ID: 27350033 [TBL] [Abstract][Full Text] [Related]
24. Retrograde Popliteal Access to Percutaneous Peripheral Intervention for Chronic Total Occlusion of Superficial Femoral Arteries. Dumantepe M Vasc Endovascular Surg; 2017 Jul; 51(5):240-246. PubMed ID: 28595481 [TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease. Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407 [TBL] [Abstract][Full Text] [Related]
26. A single center experience of Zilver PTX for femoro-popliteal lesions. Kang WY; Campia U; Didier RJ; Kiramijyan S; Koifman E; Negi SI; Lipinski MJ; Baker NC; Escarcega RO; Torguson R; Waksman R; Bernardo NL Cardiovasc Revasc Med; 2016 Sep; 17(6):399-403. PubMed ID: 27496591 [TBL] [Abstract][Full Text] [Related]
27. Vascular elastography: a novel method to characterize occluded lower limb arteries prior to endovascular therapy. Takimura H; Hirano K; Muramatsu T; Tsukahara R; Ito Y; Sakai T; Ishimori H; Nakano M; Yamawaki M; Araki M; Kato T; Kobayashi N; Sakamoto Y; Ishii A; Takama T; Tokuda T J Endovasc Ther; 2014 Oct; 21(5):654-61. PubMed ID: 25290793 [TBL] [Abstract][Full Text] [Related]
28. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease. Chan YC; Cheng SW; Cheung GC J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015 [TBL] [Abstract][Full Text] [Related]
29. Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions. Yamaguchi K; Mori S; Fukagawa T; Kishida T; Nakano T; Shirai S; Mizusawa M; Makino K; Honda Y; Tsutsumi M; Kobayashi N; Yamawaki M; Ito Y Indian Heart J; 2023; 75(6):403-408. PubMed ID: 37739220 [TBL] [Abstract][Full Text] [Related]
38. Balloon Angioplasty Versus Bailout Stenting for Isolated Chronic Total Occlusions in the Popliteal Artery. Elens M; Verhelst R; Mastrobuoni S; Bosiers MJ; Possoz J; Lacroix V; Astarci P Vasc Endovascular Surg; 2019 Feb; 53(2):126-131. PubMed ID: 30466371 [TBL] [Abstract][Full Text] [Related]
39. Impact of runoff grade after endovascular therapy for femoropopliteal lesions. Hiramori S; Soga Y; Tomoi Y; Tosaka A J Vasc Surg; 2014 Mar; 59(3):720-7. PubMed ID: 24377941 [TBL] [Abstract][Full Text] [Related]
40. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery. Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]